BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28061757)

  • 1. Comparison of risk adjustment methods in patients with liver disease using electronic medical record data.
    Xu Y; Li N; Lu M; Dixon E; Myers RP; Jolley RJ; Quan H
    BMC Gastroenterol; 2017 Jan; 17(1):5. PubMed ID: 28061757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.
    Kaplan DE; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Knott A; Pedrosa M; Pocha C; Mehta R; Duggal M; Skanderson M; Valderrama A; Taddei TH;
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2333-41.e1-6. PubMed ID: 26188137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score.
    Cho HC; Jung HY; Sinn DH; Choi MS; Koh KC; Paik SW; Yoo BC; Kim SW; Lee JH
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):51-9. PubMed ID: 21084989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the prognostic value of mortality Child Pugh Score and forecasting models of chronic liver disease in patients with decompensated cirrhosis of the Hospital Nacional Cayetano Heredia, Lima-Peru].
    Valenzuela Granados V; Salazar-Quiñones M; Cheng-Zárate L; Malpica-Castillo A; Huerta Mercado J; Ticse R
    Rev Gastroenterol Peru; 2015; 35(4):307-12. PubMed ID: 26802883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
    Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
    ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods.
    Myers RP; Quan H; Hubbard JN; Shaheen AA; Kaplan GG
    Hepatology; 2009 Feb; 49(2):568-77. PubMed ID: 19085957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N; Fagan SP; Berger DH; Awad SS
    Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
    Hassan EA; Abd El-Rehim AS
    Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Mortality in Patients With Cirrhosis: Reconsidering Expectations.
    Klein J; Spigel Z; Kalil J; Friedman L; Chan E
    Am Surg; 2022 Feb; 88(2):181-186. PubMed ID: 33502232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital frailty risk score is superior to legacy comorbidity indices for risk adjustment of in-hospital cirrhosis cases.
    Desai AP; Parvataneni S; Knapp SM; Nephew LD; Chalasani N; Ghabril MS; Orman ES
    JHEP Rep; 2024 Jan; 6(1):100955. PubMed ID: 38192536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality.
    Ward MM
    J Rheumatol; 2000 Jun; 27(6):1408-13. PubMed ID: 10852262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prognostic value of end-stage liver disease model in liver cirrhosis].
    Zhang JY; Zhang FK; Wang BE; Jia JD; Zhang ST
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
    Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
    J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
    Corneille MG; Nicholson S; Richa J; Son C; Michalek J; Wolf SE; Stewart R
    J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.
    Shaikh S; Ghani H; Memon S; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2010 Jul; 20(7):432-5. PubMed ID: 20642940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].
    Jeong EM; Hwang SG; Park HH; Park JH; Kim HT; Oh SW; Kho KH; Hong SP; Park PW; Rim GS; Kim SH
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):98-106. PubMed ID: 12824749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.